AR019902A1 - Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre. - Google Patents

Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre.

Info

Publication number
AR019902A1
AR019902A1 ARP990103304A ARP990103304A AR019902A1 AR 019902 A1 AR019902 A1 AR 019902A1 AR P990103304 A ARP990103304 A AR P990103304A AR P990103304 A ARP990103304 A AR P990103304A AR 019902 A1 AR019902 A1 AR 019902A1
Authority
AR
Argentina
Prior art keywords
blood
incides
compound containing
active principle
fat index
Prior art date
Application number
ARP990103304A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR019902A1 publication Critical patent/AR019902A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Preparado que contiene por lo menos un principio activo que incide en el índice de grasa en la sangre de un organismo, que se caracteriza por el hecho deque se encuentra en forma de parche terapéutico percutáneo, que contiene el principio activo enu na capa matriz autoadhesiva, quese puede recubrir con una capaposterior impermeable al principio activo en la cara alejada de la piel.
ARP990103304A 1998-07-09 1999-07-07 Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre. AR019902A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19830732A DE19830732B4 (de) 1998-07-09 1998-07-09 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung

Publications (1)

Publication Number Publication Date
AR019902A1 true AR019902A1 (es) 2002-03-20

Family

ID=7873488

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103304A AR019902A1 (es) 1998-07-09 1999-07-07 Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre.

Country Status (22)

Country Link
EP (1) EP1094797B1 (es)
JP (1) JP2002520272A (es)
KR (1) KR100549848B1 (es)
CN (1) CN1309377C (es)
AR (1) AR019902A1 (es)
AT (1) ATE278395T1 (es)
AU (1) AU770573B2 (es)
BR (1) BR9911941A (es)
CA (1) CA2336712C (es)
CZ (1) CZ300976B6 (es)
DE (2) DE19830732B4 (es)
ES (1) ES2230872T3 (es)
HU (1) HU226614B1 (es)
IL (2) IL140667A0 (es)
MX (1) MXPA01000126A (es)
NZ (1) NZ509215A (es)
PL (1) PL194983B1 (es)
RU (1) RU2227023C2 (es)
TR (1) TR200100021T2 (es)
TW (1) TWI237572B (es)
WO (1) WO2000002541A1 (es)
ZA (1) ZA200100171B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189890B1 (pl) * 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparat do ochrony roślin przed chorobami
AU2003264443A1 (en) * 2002-09-20 2004-04-08 Kowa Co., Ltd. Preparation for external use
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
JP2006515026A (ja) * 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド 乳房の疾患および障害の処置のための薬学的調製物
RU2261705C1 (ru) * 2004-01-29 2005-10-10 Медведев Илья Николаевич Способ лечения тромбоцитопатии при метаболическом синдроме
US20070166360A1 (en) * 2004-03-31 2007-07-19 Kowa Co., Ltd. External preparation
DE602005020393D1 (de) 2004-06-01 2010-05-20 Hisamitsu Pharmaceutical Co Adhäsive Pflaster
JP4986411B2 (ja) * 2004-06-01 2012-07-25 久光製薬株式会社 貼付剤
US20050281868A1 (en) * 2004-06-21 2005-12-22 Fairfield Clinical Trials, Llc Transdermal delivery system for statin combination therapy
JP4824963B2 (ja) * 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
EP1996118A4 (en) * 2006-03-07 2013-03-06 Osteoscreen Ip Llc STRENGTHENING BONES AND CARTILES BY HMG-CO-A REDUCTASE INHIBITOR
KR100817274B1 (ko) * 2006-08-21 2008-03-27 삼성전기주식회사 발광 다이오드 패키지 및 그 제조방법
RU2392929C2 (ru) * 2007-06-20 2010-06-27 Общество С Ограниченной Ответственностью "Гамаветфарм" Средство для стимуляции выброса стволовых кроветворных клеток в кровоток
EP3556359A4 (en) 2016-12-19 2020-08-05 Nutritape, S.L. ENERGIZING PLASTER FOR SPORTS
EP3938076A1 (en) 2019-03-12 2022-01-19 Corning Incorporated Ceramic honeycomb body with skin
TWI803052B (zh) * 2021-11-12 2023-05-21 佛教慈濟醫療財團法人 經皮遞送裝置及其使用及製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
WO1996011022A1 (en) * 1994-10-05 1996-04-18 Hisamitsu Pharmaceutical Co., Inc. DRUG COMPOUNDING INGREDIENTS COMPRISING N-SUBSTITUTED-o-TOLUIDINE DERIVATIVE AND PERCUTANEOUSLY ABSORBABLE PREPARATION
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans

Also Published As

Publication number Publication date
BR9911941A (pt) 2001-03-27
DE19830732A1 (de) 2000-01-13
DE59910758D1 (de) 2004-11-11
HUP0102718A2 (hu) 2002-03-28
CA2336712C (en) 2008-09-09
CZ200193A3 (en) 2001-05-16
IL140667A (en) 2007-05-15
TR200100021T2 (tr) 2001-05-21
CZ300976B6 (cs) 2009-09-30
MXPA01000126A (es) 2002-06-04
PL194983B1 (pl) 2007-07-31
DE19830732B4 (de) 2008-11-13
ZA200100171B (en) 2001-08-10
HU226614B1 (en) 2009-04-28
TWI237572B (en) 2005-08-11
KR100549848B1 (ko) 2006-02-06
EP1094797A1 (de) 2001-05-02
CN1309377C (zh) 2007-04-11
AU770573B2 (en) 2004-02-26
KR20010079513A (ko) 2001-08-22
PL345510A1 (en) 2001-12-17
NZ509215A (en) 2003-04-29
ES2230872T3 (es) 2005-05-01
WO2000002541A1 (de) 2000-01-20
HUP0102718A3 (en) 2002-12-28
AU5157499A (en) 2000-02-01
CA2336712A1 (en) 2000-01-20
JP2002520272A (ja) 2002-07-09
IL140667A0 (en) 2002-02-10
CN1308525A (zh) 2001-08-15
RU2227023C2 (ru) 2004-04-20
ATE278395T1 (de) 2004-10-15
EP1094797B1 (de) 2004-10-06

Similar Documents

Publication Publication Date Title
AR019902A1 (es) Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre.
SE8605383L (sv) Flerfaldigt indelade transdermala och dermala plaster
ATE200210T1 (de) Transdermales medikamentenverabreichungssystem
PE20000721A1 (es) Articulo absorbente que incluye un agente modificador de heces basado en calcio
CO5040226A1 (es) Producto de braga absorbente
ES2185001T3 (es) Suela exterior transpirable.
ES2196055T3 (es) Dispositivo transdermico que contiene polivinilpirrolidona como intensificador de la solubilidad.
ATE447888T1 (de) Tragbarer ambulanter datenrekorder
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
BR0214411A (pt) Artigo descartável próprio para ser usado dotado de um elemento de sensação de umidade
FI95539C (fi) Transdermaalinen järjestelmä, sen valmistusmenetelmä ja käyttö
MY196789A (en) Catheter securement device with window
ES538367A0 (es) Procedimiento para la obtencion de un sistema para el suministro de un producto activo a la piel
AU6694500A (en) Cosmetic strip with an agent for inducing a temperature change
PT1131039E (pt) Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
EA200501224A1 (ru) Стойкий к уф - излучению трансдермальный пластырь
MY103355A (en) Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
ES2116572T3 (es) Parche para la administracion percutanea de sustancias de contenido quimicamente basico, farmaceuticamente eficaces y volatiles, y un metodo para su fabricacion.
AR021459A1 (es) PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS.
NO306378B1 (no) Transdermalt terapeutisk system inneholdende det aktive stoffet 17-<beta>-östradiol, samt fremgangsmaate for fremstilling av dette
ES2063172T3 (es) Sistema terapeutico superficial con una sustancia activa antineoplasica, en especial 5-fluoruracilo.
TR200000407T2 (tr) Etken madde olarak scopolaminbase içeren transdermal terapötik sistem
ES2141548T3 (es) Preparado farmaceutico de superficie estabilizada para su aplicacion sobre la piel.
BRPI0414585A (pt) emplastro adesivo

Legal Events

Date Code Title Description
FG Grant, registration